Towards Healthcare
Molecular Diagnostics Market Captures USD 27.21 Bn by 2034

Molecular Diagnostics Market Size, Advancing Early Detection and Targeted Therapy

Projections indicate that, molecular diagnostics industry is projected to rise from USD 16.24 billion in 2024 to USD 27.21 billion by 2034, reflecting a CAGR of 5.3% over the next decade. The molecular diagnostics is growing rapidly, driven by advancements in genetic testing, infectious disease detection, and personalized medicine. It enables precise, fast, and early diagnosis using DNA/RNA analysis, improving patient outcomes. Demand is rising with innovations in PCR, NGS, and point-of-care tests.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Molecular Diagnostics Market Assessment

  • Overview
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Molecular Diagnostics Market Assessment

  • Overview
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Europe Molecular Diagnostics Market Assessment

  • Overview
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Asia Pacific Molecular Diagnostics Market Assessment

  • Overview
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Middle East and Africa Molecular Diagnostics Market Assessment

  • Overview
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

South America Molecular Diagnostics Market Assessment

  • Overview
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Company Profiles

  • BD
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic Inc. (Gen Probe)
  • Illumina, Inc.
  • Grifols, S.A.
  • QIAGEN
  • F. Hoffmann-La Roche, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation

Conclusion & Recommendations

  • Insight Code: 5150
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Stringent regulatory processes for approval of new diagnostic tests, high initial investment costs for advanced technologies, and reimbursement limitations in certain regions pose challenges to market growth. Additionally, ensuring the accessibility of these tests in resource-limited settings requires innovative solutions.

Focusing on developing innovative and cost-effective diagnostic solutions, strategic partnerships with healthcare providers and laboratories, expanding into emerging markets, and actively participating in research and development to stay ahead of the competition are key strategies for success in the molecular diagnostics market. Additionally, ensuring compliance with regulatory requirements and advocating for favorable reimbursement policies are crucial aspects.

Advancements in technologies like next-generation sequencing (NGS), digital PCR, microfluidics, and CRISPR hold immense potential for the molecular diagnostics market. These innovations offer greater sensitivity, specificity, faster turnaround times, and the ability to perform multiplex testing for multiple targets simultaneously, leading to more comprehensive and efficient diagnostics.

The U.S. Food and Drug Administration, KFF (Kaiser Family Foundation), World Health Organization, National Institute of Health and Centers for Disease Control and Prevention.